Sarcandra glaber dispersant tablets
A technology of Zhongjiefeng and dispersible tablets is applied in the directions of antitumor drugs, medical raw materials derived from angiosperm subphylum, and pill delivery, etc., which can solve the problems such as the lack of disintegration time of Zongjiefeng dispersible tablets, and achieves great room for manoeuvre, The effect of improving disintegration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0053] The traditional Chinese medicine raw material of Zhongjiefeng dispersible tablet: air-dried extract of Zhongjiefeng.
[0054] The weight percentage of traditional Chinese medicine extract and auxiliary materials of Zhongjiefeng Dispersible Tablets: 35.3% of fine powder of Zhongjiefeng extract, 14.5% of sodium carboxymethyl starch, 12.2% of low-substituted hydroxypropyl cellulose, and 14.2% of microcrystalline cellulose , lactose 18.5%, polyvinylpyrrolidone 3.1%, magnesium stearate 2.2%.
[0055] Zhongjiefeng Dispersible Tablets are obtained according to the following specific steps: take Zhongjiefeng, chop it up, add 8 times of water to decoct three times, each time for 1 hour, combine the decoction, filter, the filtrate is concentrated into a thick paste with a density of 1.23, and dried Dried extract, crushed to make the fine powder of Sargassum extract. First pass the above materials through a 100-mesh sieve, and mix the fine powder of Sargassum extract with filler ...
Embodiment 2
[0057] The fine powder of Sargassum extract by weight 30%, sodium carboxymethylcellulose 22%, microcrystalline cellulose 11%, cross-linked polyvinylpyrrolidone 16%, polyvinylpyrrolidone 5%, lactose 9%, polyethylene Pyrrolidone 4%, micronized silica gel 1%, magnesium lauryl sulfate 2%. All the other are with embodiment 1.
Embodiment 3
[0059] 40% by weight of fine powder of Sargassum extract, 20% sodium carboxymethyl starch, 15% croscarmellose sodium, 6% crospovidone, 3% low-substituted hydroxypropyl cellulose , mannitol 6%, polyvinylpyrrolidone 5%, micronized silica gel 3%, magnesium stearate 1%, HLB=15-16 sucrose fatty acid ester 1%. Sucrose fatty acid ester is P-1570 or P-1670 or LWA-1570, all the other are the same as embodiment 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com